The risk may arise when a representative of one company discloses an internal policy approach to managing MFN, particularly if that approach is likely to be reflected in a future submission or engagement with government. …
A 'meeting of minds' and the risk of not being able to 'unknow' information
February 9, 2026 Latest NewsBioPharma
Latest Video
Georgia Forrest
New Stories
-
ViiV invests in HIV-focused initiatives through Positive Action Community Grants program
February 9, 2026 - - Latest News -
A 'meeting of minds' and the risk of not being able to 'unknow' information
February 9, 2026 - - Latest News -
Women’s health reforms deliver savings and expanded access one year on
February 9, 2026 - - Latest News -
A new option for Kiwis with Lilly confirming Mounjaro launch in New Zealand
February 9, 2026 - - Latest News -
The race for the Pharma Cup heats up as teams chase the summit
February 8, 2026 - - Latest News -
The leaders will be thinking about this situation like a game of chess
February 7, 2026 - - Latest News -
TrumpRx launches based on global pricing promise in an insurance-dominated reality
February 7, 2026 - - Latest News